The global Blunt Filter Needles market size is predicted to grow from US$ 59 million in 2025 to US$ 119 million in 2031; it is expected to grow at a CAGR of 12.3% from 2025 to 2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry.

This Insight Report provides a comprehensive analysis of the global Blunt Filter Needles landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

Segmentation by Type

• 0.98
• 0.99
• Others

Segmentation by Application

• Hospitals and Clinics
• Ambulatory Surgery Center

Market by Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Company’s Coverage

• BD
• Yangzhou Medline Industry Co., Ltd.
• Myco Medical
• NeoMed, Inc.
• Smiths Medical
• Al Shifa
• Cardinal Health
• Vitrex Medical
• Shanghai Eastern Medtech Co., Ltd.
• Sentra Medical

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Blunt Filter Needles market?
• What factors are driving Blunt Filter Needles market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Blunt Filter Needles market opportunities vary by end market size?
• How does Blunt Filter Needles break out by Type, by Application?